Position in SCLX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$101
+$15 QoQ
Shares Held
13
-38.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 72 holders
Holding Since
Mar 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HARBOUR INVESTMENTS, INC. holds $128,781,101 across 17 Drug Manufacturers - General names. SCLX ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
221,662 | $55,779,025 | |
| 2 | LLY |
ELI LILLY & Co
|
27,683 | $33,203,823 | |
| 3 | JNJ |
Johnson & Johnson
|
69,981 | $17,773,074 | |
| 4 | MRK |
Merck & Co., Inc.
|
40,366 | $5,187,031 | |
| 5 | PFE |
Pfizer Inc
|
141,011 | $3,395,544 | |
| 6 | AMGN |
Amgen Inc
|
8,295 | $3,003,785 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
50,112 | $2,887,453 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
22,237 | $2,809,422 |
All Filings in SCLX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $101 | 13 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $86 | 13 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $48 | 4 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $78 | 4 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $47 | 8 | Shares | Sole | 2025-07-28 | |
| 2023-06-30 | $1,726 | 310 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,542 | 310 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||